Vical Incorporated

Vical pushing ahead with genital herpes vaccine trials

Some advancement on the herpes vaccine front:┬áSan Diego biotech Vical recently kicked off a Phase 1/2 trial of its Vaxfectin genital herpes vaccine – a therapeutic inoculation that’s melded vaccine and DNA technologies. Here’s how it works: Vical’s approach directs the immune response in two ways: It teaches immune cells to develop weapons against the […]